Implementation of Guidelines for the Prevention of Diabetic Nephropathy

Diabetes Care

Volumn 27, Issue 3, 2004, Pages 803-804

  Fagerudd, Johan ^b   Forsblom, Carol ^b   Pettersson Fernholm, Kim ^b   Groop, Per Henrik ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRACTICE GUIDELINE; SMOKING CESSATION;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FINLAND; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS;

EID: 1442348810     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.3.803     Document Type: Article

References (17)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Haire-Joshu D, Glasgow RE, Tibbs TL: Smoking and diabetes. Diabetes Care 26 (Suppl. 1):S89-S90, 2003
3. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285:685-688, 1982
4. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 297:1092-1095, 1988
5. Pettersson-Fernholm K, Forsblom C, Perola M, Groop PH: Polymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patients. Kidney Int 63:1205-1210, 2003
6. Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH: The functional - 374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52:891-894, 2003
7. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080-1084, 1995
8. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563-2569, 2002
9. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285, 1994
10. Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, Fuller JH: Risk factors for progression to proliferative diabetic retinopathy in the EURO-DIAB Prospective Complications Study. Diabetologia 44:2203-2209, 2001
11. Gudbjornsdottir S, Cederholm J, Nilsson PM, Eliasson B: The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26:1270-1276, 2003
12. Helakorpi S, Patja K, Prättälä R, Uutela A: Health Behaviour and Health Among Finnish Adult Population: Spring 2002. Helsinki, Finland, Finnish National Public Health Institute, 2003
13. Birkett NJ, Donner AP, Maynard MD: Assessing hypertension control in the community: the need for follow-up measurements to ensure clinical relevance. CMAJ 136:595-600, 1987
14. Soedamah-Muthu SS, Colhoun HM, Abrahamian H, Chan NN, Mangili R, Reboldi GP, Fuller JH, The EPCSG: Trends in hypertension management in type 1 diabetes across Europe, 1989/1990-1997/1999. Diabetologia 45:1362-1371, 2002
15. Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J: Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden. J Hum Hypertens 17:37-44, 2003
16. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18, 1994
17. Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH: Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26:1258-1264, 2003